Leerink Partnrs Analysts Lower Earnings Estimates for UNH

UnitedHealth Group Incorporated (NYSE:UNH) – Equities researchers at Leerink Partnrs lowered their Q2 2025 earnings per share (EPS) estimates for shares of UnitedHealth Group in a research report issued on Tuesday, October 15th. Leerink Partnrs analyst W. Mayo now anticipates that the healthcare conglomerate will earn $7.47 per share for the quarter, down from their prior forecast of $7.61. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.68 per share. Leerink Partnrs also issued estimates for UnitedHealth Group’s Q3 2025 earnings at $7.51 EPS.

Several other equities analysts have also recently issued reports on UNH. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Argus lifted their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $615.16.

UnitedHealth Group Price Performance

NYSE UNH opened at $566.00 on Thursday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $608.63. The stock’s fifty day moving average price is $584.20 and its 200 day moving average price is $533.07. The company has a market cap of $522.66 billion, a price-to-earnings ratio of 37.53, a PEG ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm earned $6.56 earnings per share.

Institutional Trading of UnitedHealth Group

Several hedge funds have recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $27,000. Macroview Investment Management LLC increased its position in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group in the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s payout ratio is presently 55.70%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.